Table 2.
Characteristics | Number of procedures (%) |
---|---|
Targeted duct | |
CBD | 813 (90.8) |
PD | 63 (7.0) |
Both | 10 (1.1) |
Total cannulation attempts* | |
1 or 2 | 238 (43.6) |
3–5 | 103 (18.9) |
6–10 | 52 (9.5) |
Greater than 10 | 86 (15.8) |
Cannulation time, minutes—mean (SD)* | 5.12 (8.21) |
Pancreatic duct cannulation or double wire usage† | 153 (29.9) |
Maneuvers performed* | |
Standard sphincterotomy | 484 (88.6) |
Balloon sphincteroplasty | 99 (18.1) |
Precut sphincterotomy (any kind) | 100 (18.3) |
Needle-knife papillotomy | 61 (11.2) |
Cholangioscopy performed | 24 (2.7) |
Pancreatoscopy performed | 2 (0.2) |
Procedure time, minutes—mean (SD) | 25.0 (16.5) |
General anaesthesia used | |
Yes | 107 (12.0) |
No | 788 (88.0) |
Mean doses of sedating medications used‡ | |
Midazolam, mg IV—mean (SD) | 5.53 (7.39) |
Fentanyl, µg IV—mean (SD) | 94.25 (38.76) |
Diphenhydramine, mg IV—mean (SD) | 46.87 (9.61) |
Procedural success | 806 (90.1) |
Reasons for procedural failure | |
Sedation-related issues | 4 (0.4) |
Inability to locate papilla of interest | 5 (0.6) |
Inability to cannulate duct of interest | 46 (5.1) |
Inability to clear duct of interest or relieve obstruction | 37 (4.1) |
Stent(s) placed in CBD | 85 (9.5) |
CBD Common bile duct; IV Intravenous; PD Pancreatic duct; SD Standard deviation.
*Calculated only from 546 procedures with native papillae; †calculated only from procedures with native papillae where the CBD was the target, n = 512; ‡calculated only from procedures where conscious sedation was used, n = 788.